Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

SVRA

Savara Inc

Pharmaceutical Preparations · SIC 2834CIK 1160308Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
—
Net Income FY2025
$(119.0M)
EPS (Basic, as reported)
$-0.53
Net Margin FY2025
—
ROE FY2025
-58.5%
Total Equity
$203.0M
Shares Out
205M
Business description

Savara Inc — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY1997–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 0 → 0
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue00—00—————
Gross profit——————————
Selling, general & administrative(9)—————————
General & administrative(3)(11)(11)(13)(14)(12)(11)(16)(25)(42)
Total operating expenses(37)(30)(70)(79)(50)(41)(39)(60)(103)(124)
Operating income(36)(30)(70)(79)(49)(41)(39)(60)(103)(124)
Interest expense(2)(1)————————
Interest & investment income0—————————
Other income (expense), net0(3)010(2)1575
Pre-tax income(39)(33)(70)(78)(50)(43)(38)(55)(96)(119)
Income tax expense(2)(4)(9)—————00
Net income(36)(30)(62)(78)(50)(43)(38)(55)(96)(119)
EPS — basic—————($0.32)($0.25)($0.33)($0.48)($0.53)
EPS — diluted—————($0.32)($0.25)($0.33)($0.48)($0.53)
Shares outstanding — basic (M)—————134153165198222
Shares outstanding — diluted (M)—————134153165198222

Showing the latest 10 of 29 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.